I agree with you. But we shouldn't be too optimistic about the expectations, afterwards the disappointment could be even greater if certain goals are not achieved.
In the short term, nameplate production and a permanent reduction in shipping costs will be important because these will have a direct impact on profits / losses.
The scoping study, which I was actually expecting this week, will, in my opinion, be published early next week. Between Christmas and New Years, I don't think it makes any sense to publish such a study.
In the medium term, important PFS for battery manganese and a possible acceptance agreement with a car manufacturer or battery manufacturer.
Question: Since I am from Germany, I do not have an overview of the composition of the various indices in Australia. Is E25 currently in an index (for commodities) or is there a prospect of being included in an index at some point? What are the requirements here?
- Forums
- ASX - By Stock
- The Dawn of EV
E25
element 25 limited
Add to My Watchlist
0.00%
!
22.5¢

I agree with you. But we shouldn't be too optimistic about the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.5¢ | $21.94K | 100.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 62609 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2779 | 0.215 |
3 | 28857 | 0.210 |
2 | 8107 | 0.205 |
7 | 59405 | 0.200 |
3 | 13077 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 62609 | 2 |
0.230 | 72958 | 1 |
0.235 | 24800 | 2 |
0.240 | 252084 | 2 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online